[DPHARMA] YoY TTM Result on 31-Mar-2019 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
21-May-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Mar-2019 [#1]
Profit Trend
QoQ- 7.71%
YoY- 17.73%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 658,662 577,643 584,789 515,849 477,940 354,464 304,911 13.69%
PBT 86,454 81,606 69,750 65,197 52,929 32,714 47,508 10.48%
Tax -18,094 -18,943 -15,381 -13,738 -9,746 -5,098 -9,864 10.63%
NP 68,360 62,663 54,369 51,459 43,183 27,616 37,644 10.44%
-
NP to SH 68,360 62,663 54,369 51,459 43,710 27,890 37,659 10.44%
-
Tax Rate 20.93% 23.21% 22.05% 21.07% 18.41% 15.58% 20.76% -
Total Cost 590,302 514,980 530,420 464,390 434,757 326,848 267,267 14.11%
-
Net Worth 621,987 635,424 540,662 496,410 206,429 463,071 457,740 5.24%
Dividend
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Div 20,482 45,783 40,733 30,674 23,711 19,142 5,682 23.81%
Div Payout % 29.96% 73.06% 74.92% 59.61% 54.25% 68.64% 15.09% -
Equity
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Net Worth 621,987 635,424 540,662 496,410 206,429 463,071 457,740 5.24%
NOSH 941,765 706,026 684,383 661,881 278,959 278,959 278,959 22.46%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin 10.38% 10.85% 9.30% 9.98% 9.04% 7.79% 12.35% -
ROE 10.99% 9.86% 10.06% 10.37% 21.17% 6.02% 8.23% -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
RPS 70.95 81.82 85.45 77.94 171.33 127.07 109.24 -6.93%
EPS 7.36 8.88 7.94 7.77 15.67 10.00 13.49 -9.60%
DPS 2.21 6.48 5.95 4.63 8.50 6.86 2.04 1.34%
NAPS 0.67 0.90 0.79 0.75 0.74 1.66 1.64 -13.85%
Adjusted Per Share Value based on latest NOSH - 661,881
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
RPS 68.42 60.01 60.75 53.59 49.65 36.82 31.67 13.69%
EPS 7.10 6.51 5.65 5.35 4.54 2.90 3.91 10.44%
DPS 2.13 4.76 4.23 3.19 2.46 1.99 0.59 23.84%
NAPS 0.6461 0.6601 0.5616 0.5157 0.2144 0.481 0.4755 5.24%
Price Multiplier on Financial Quarter End Date
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Date 31/03/22 31/03/21 31/03/20 29/03/19 30/03/18 31/03/17 31/03/16 -
Price 1.49 2.75 1.39 1.28 2.80 2.31 2.55 -
P/RPS 2.10 3.36 1.63 1.64 1.63 1.82 2.33 -1.71%
P/EPS 20.23 30.98 17.50 16.46 17.87 23.10 18.90 1.13%
EY 4.94 3.23 5.72 6.07 5.60 4.33 5.29 -1.13%
DY 1.48 2.36 4.28 3.62 3.04 2.97 0.80 10.79%
P/NAPS 2.22 3.06 1.76 1.71 3.78 1.39 1.55 6.16%
Price Multiplier on Announcement Date
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Date 17/05/22 03/05/21 18/05/20 21/05/19 28/05/18 22/05/17 18/05/16 -
Price 1.51 2.93 1.72 1.36 3.35 2.32 2.40 -
P/RPS 2.13 3.58 2.01 1.75 1.96 1.83 2.20 -0.53%
P/EPS 20.51 33.01 21.65 17.49 21.38 23.20 17.79 2.39%
EY 4.88 3.03 4.62 5.72 4.68 4.31 5.62 -2.32%
DY 1.46 2.21 3.46 3.41 2.54 2.96 0.85 9.43%
P/NAPS 2.25 3.26 2.18 1.81 4.53 1.40 1.46 7.47%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment